China-based WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization...
The International Vaccine Institute (IVI) has opened its new Biorepository, a global centre for biological resources, at...
South Korea-based Coreline Soft, a global leader in artificial intelligence (AI)-based medical solutions, has annou...
Brexogen, a leading biotechnology company specialising in exosome-based therapeutics, has announced a technology transfe...
Novotech, a global full-service clinical Contract Research Organisation (CRO) that partners with biotech and small to mi...
Taiwan-based startup Health2Sync, a leading provider of digital therapeutics solutions for chronic diseases, is experien...
SK Bioscience reported strong revenue growth in Q4 2024, primarily driven by the consolidation of IDT Biologika, expansi...
South Korea-based Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significant strides ...
South Korea-based SK bioscience has announced that it is the only private company to participate in the World Health Org...
Daewoong Pharmaceutical, a leading healthcare company in Korea, has announced the official launch of its high-purity, hi...
South Korea-based OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced a global licensing...
LG AI Research recently signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,&...
South Korea-based Hyundai Bioscience, and the Drugs for Neglected Diseases initiative (DNDi), an international non-profi...
The Ministry of Science and ICT and the Korea Research Institute of Bioscience and Biotechnology have announced the "Top...
Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, ha...
South Korea-based SK bioscience, and global healthcare leader Sanofi, are strengthening their partnership to jointly tar...
South Korea's GI Innovation has signed a Memorandum of Understanding (MoU) with LaNova Medicines for the development of ...
GordonMD Global Investments LP, a US-based investment manager focused exclusively on global public and private biop...
